Join to View Full Profile
9200 W Wisconsin Ave# HematoloMilwaukee, WI 53226
Phone+1 414-805-6800
Fax+1 414-805-4944
Dr. Chaudhary is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 2013 - 2015
West Virginia UniversityFellowship, Hematology and Medical Oncology, 2012 - 2013- West Virginia UniversityResidency, Internal Medicine, 2009 - 2012
King Edward Medical UniversityClass of 2005
Certifications & Licensure
WI State Medical License 2013 - 2025
WV State Medical License 2012 - 2014
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients with Hormone Receptor-Positive HER2-negative Breast Cancer Start of enrollment: 2024 Sep 30
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsA Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer.Sailaja Kamaraju, Amy M Fowler, Sergey Tarima, Lubna N Chaudhary, Mark E Burkard
Clinical Breast Cancer. 2025-04-01 - Cardiac MRI for differentiating chemotherapy-induced cardiotoxicity in sarcoma and breast cancer.El-Sayed H Ibrahim, Lubna Chaudhary, Yee-Chung Cheng, Antonio Sosa, Dayeong An
Radiology and Oncology. 2025-03-01 - 1 citationsDetrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemothera...Jayasree Krishnan, Archit Patel, Arya Mariam Roy, Malak Alharbi, Ankita Kapoor
Clinical Breast Cancer. 2024-12-01
Press Mentions
Data Continue to Help Shape CDK4/6 Inhibitor Selection, Sequencing in HR+ Breast CancerDecember 7th, 2024- Medical College of Wisconsin Scientists Find New Marker That Predicts Early Recurrence of Breast CancerJanuary 25th, 2023
- Medical College of Wisconsin Scientists Find New Marker That Predicts Early Recurrence of Breast CancerJanuary 25th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
